Detection and Relative Quantification of Fusobacterium Nucleatum in Head and Neck Cancers

Key Points

• Fusobacterium nucleatum levels are significantly higher in head and neck cancer samples than in controls, indicating potential as a biomarker.
• The study analyzed tissue samples from cancer patients compared to non-cancerous tissues, revealing these significant differences.
• Detection used advanced molecular techniques to identify and quantify Fusobacterium nucleatum in the samples collected.
• The findings support the need for further exploration of Fusobacterium nucleatum in cancer diagnostics, emphasizing its potential as a therapeutic target.